MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with P

Paliperidone

Paliperidone 3mg modified-release tablets

Use with caution

Stability notes for Paliperidone 3mg modified-release tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the product Invega 3mg modified-release tablets (Janssen-Cilag Ltd).

Supplier

Invega 3mg modified-release tablets (Janssen-Cilag Ltd)

Paliperidone 6mg modified-release tablets

Use with caution

Stability notes for Paliperidone 6mg modified-release tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the product Invega 6mg modified-release tablets (Janssen-Cilag Ltd).

Supplier

Invega 6mg modified-release tablets (Janssen-Cilag Ltd)

Paliperidone 9mg modified-release tablets

Use with caution

Stability notes for Paliperidone 9mg modified-release tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the product Invega 9mg modified-release tablets (Janssen-Cilag Ltd).

Supplier

Invega 9mg modified-release tablets (Janssen-Cilag Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.